-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Initiates Coverage On Abivax with Underperform Rating, Announces Price Target of $110

Benzinga·02/24/2026 13:48:12
Listen to the news
Wedbush analyst David Nierengarten initiates coverage on Abivax (NASDAQ:ABVX) with a Underperform rating and announces Price Target of $110.